The European Bank for Reconstruction and Development has agreed to invest 6 million euros to support European Metals Holdings' (ASX:EMH) development of the Cinovec lithium project in the Czech Republic. Executive Chairman Keith Coughlan discusses the significance of the placement and the momentum behind lithium in Europe.
Copyright 2023 – Finance News Network
Source: Finance News Network
10 Dec 2020 - Lepidico Limited (ASX:LPD) Managing Director Joe Walsh discusses the company's strategic collaboration and technology licence agreement with Cornish Lithium, permitting for its plant in Abu Dhabi, and interest in its critical minerals from the United States International Development Finance Corporation.
Read More01 Jun 2020 - NetLinkz Limited (ASX:NET) Executive Chairman & CEO James Tsiolis provides an update on the company's suite of networking solutions, the market opportunity and progress with partners.
Read More22 Jun 2023 - Lake Resources Limited (ASX:LKE) Managing Director David Dickson discusses the company's two-phase strategy.
Read More16 Sep 2024 - Quantum Brilliance CEO Mark Luo discusses how his company is pioneering quantum computing with synthetic diamonds, offering a miniaturised and energy-efficient alternative. He highlights the company's rapid growth since its spin-out from the Australian National University, its unique approach to quantum technology and the enormous commercial potential of quantum at the edge.
Read More26 Sep 2022 - European Metals Holdings Limited (ASX:EMH) discusses its Cinovec project, the largest hard rock lithium resource in Europe.
Read More15 Jul 2020 - Recce Pharmaceuticals Limited (ASX:RCE) Executive Director James Graham provides an update on positive data against a range of persistent bacteria using the company's synthetic antibiotic RECCE 327, commencement of Phase I human clinical trial in 2H20 and key priorities.
Read More14 July 2025 - Progress in cancer and autoimmune disease treatment
Read More11 Aug 2020 - Regeneus (ASX:RGS) CEO, Leo Lee talks about its collaboration with Kyocera of Japan to market Progenza its cell therapy treatment for anti-inflammatory treatment and repair of damaged or diseased tissue.
Read More01 Mar 2022 - IVE Group Limited (ASX:IGL) Executive Chairman Geoff Selig discusses the highlights of the company's recently released results, key drivers and outlook.
Read More26 Aug 2025 - Technical breakthroughts, customer traction and the road ahead
Read More
